IDH1 and oligodendroglioma: Since IDH1 mutations relate to both astrocytoma and oligodendroglioma, selecting the correct medium is essential to keep the IDH1 mutated model similar to the patient’s condition, because using an inaccurate medium can change the sensitivity of cells to different drugs.